Advances and Novel Treatment Options in Metastatic Melanoma

Open Access

Advances and Novel Treatment Options in Metastatic Melanoma

The book presents several studies reporting advances on melanoma pathogenesis, diagnosis and therapy. It represents a milestone on the state of the art, updated at 2021, and also presents the current knowledge on the future developments in melanoma field.

Saved in:
Bibliographic Details
HerausgeberIn:
Del Bufalo, Donatella
Carè, Alessandra
Sonstige:
Facchiano, Antonio
Del Bufalo, Donatella
Carè, Alessandra
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (528 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546100404498
ctrlnum (CKB)5400000000045281
(oapen)https://directory.doabooks.org/handle/20.500.12854/79644
(EXLCZ)995400000000045281
collection bib_alma
record_format marc
spelling Facchiano, Antonio edt
Advances and Novel Treatment Options in Metastatic Melanoma
Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
1 electronic resource (528 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Open access Unrestricted online access star
The book presents several studies reporting advances on melanoma pathogenesis, diagnosis and therapy. It represents a milestone on the state of the art, updated at 2021, and also presents the current knowledge on the future developments in melanoma field.
English
Medicine bicssc
melanoma
invasion
WNT5A
MARCKS
phosphorylation
MANS peptide
nanoparticles
cell therapy
tumor microenvironment
sex/gender
sex-hormones
immunity
microRNAs
immunotherapy
BRAF-mutant melanoma
BRAF inhibitor
mechanism of action
targeted therapy
tumour microenvironment
plasmacytoid dendritic cells
lactate dehydrogenase
TLR
interferon
CXCL10
TPC2
HIPPO
SOCE
metastasis
essential oils
angiogenesis
apoptosis
uveal melanoma (UM)
metastatic uveal melanoma (mUM)
prognostication
adjuvant therapy
metastatic therapy
metastatic dormancy
liver-directed-therapies
targeted-therapy
combined therapy
protein tyrosine phosphatase
PTPs inhibitors
melanoma immune infiltrate
BRAF inhibitors
microenvironment
resistance
therapy
therapeutic resistance
exosomes
extracellular vesicles
diagnosis
prognosis
ctDNA
liquid biopsy
prediction
patient stratification
BRAF
arthralgia
rheumatoid arthritis
carbonic anhydrase
hedgehog
cyclopamine
small molecules
acetazolamide
motility
metalloproteinases
FAK
cancer
mucosal melanoma
nivolumab
pembrolizumab
ipilimumab
radiotherapy
cholinergic system
acetylcholine
muscarinic receptors
nicotinic receptors
melanoma metastasis
ShcD adaptor protein
amoeboid motility
Rac1
DOCK4
melanoma PDX
target therapy
cancer stem cells
slow cycling phenotype
drug resistance
OXPHOS
lipid metabolism
cancer associated fibroblast
melanomagenesis
biomarkers
checkpoint inhibitor
PD-1
melanoma markers
cytokines
machine learning
Support Vector Machine
principal component analysis
BCL2L10
STAT3
cytotoxicity
survival
ABT-737
Bcl-2 family
ML258
HuR
MITF
metastases
siRNA
3-0365-3304-4
3-0365-3303-6
Del Bufalo, Donatella edt
Carè, Alessandra edt
Facchiano, Antonio oth
Del Bufalo, Donatella oth
Carè, Alessandra oth
language English
format eBook
author2 Del Bufalo, Donatella
Carè, Alessandra
Facchiano, Antonio
Del Bufalo, Donatella
Carè, Alessandra
author_facet Del Bufalo, Donatella
Carè, Alessandra
Facchiano, Antonio
Del Bufalo, Donatella
Carè, Alessandra
author2_variant a f af
b d d bd bdd
a c ac
author2_role HerausgeberIn
HerausgeberIn
Sonstige
Sonstige
Sonstige
title Advances and Novel Treatment Options in Metastatic Melanoma
spellingShingle Advances and Novel Treatment Options in Metastatic Melanoma
title_full Advances and Novel Treatment Options in Metastatic Melanoma
title_fullStr Advances and Novel Treatment Options in Metastatic Melanoma
title_full_unstemmed Advances and Novel Treatment Options in Metastatic Melanoma
title_auth Advances and Novel Treatment Options in Metastatic Melanoma
title_new Advances and Novel Treatment Options in Metastatic Melanoma
title_sort advances and novel treatment options in metastatic melanoma
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2022
physical 1 electronic resource (528 p.)
isbn 3-0365-3304-4
3-0365-3303-6
illustrated Not Illustrated
work_keys_str_mv AT facchianoantonio advancesandnoveltreatmentoptionsinmetastaticmelanoma
AT delbufalodonatella advancesandnoveltreatmentoptionsinmetastaticmelanoma
AT carealessandra advancesandnoveltreatmentoptionsinmetastaticmelanoma
status_str n
ids_txt_mv (CKB)5400000000045281
(oapen)https://directory.doabooks.org/handle/20.500.12854/79644
(EXLCZ)995400000000045281
carrierType_str_mv cr
is_hierarchy_title Advances and Novel Treatment Options in Metastatic Melanoma
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
_version_ 1796651970659876864
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04724nam-a2201669z--4500</leader><controlfield tag="001">993546100404498</controlfield><controlfield tag="005">20231214133000.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202203s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000045281</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/79644</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000045281</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Facchiano, Antonio</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances and Novel Treatment Options in Metastatic Melanoma</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (528 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book presents several studies reporting advances on melanoma pathogenesis, diagnosis and therapy. It represents a milestone on the state of the art, updated at 2021, and also presents the current knowledge on the future developments in melanoma field.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">WNT5A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MARCKS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phosphorylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MANS peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sex/gender</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sex-hormones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRAF-mutant melanoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRAF inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mechanism of action</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumour microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plasmacytoid dendritic cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lactate dehydrogenase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TLR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interferon</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CXCL10</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TPC2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIPPO</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SOCE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">essential oils</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">apoptosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uveal melanoma (UM)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic uveal melanoma (mUM)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognostication</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adjuvant therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic dormancy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liver-directed-therapies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted-therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">combined therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein tyrosine phosphatase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PTPs inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma immune infiltrate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRAF inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extracellular vesicles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ctDNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prediction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">patient stratification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRAF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arthralgia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbonic anhydrase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hedgehog</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cyclopamine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">small molecules</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acetazolamide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">motility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metalloproteinases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FAK</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucosal melanoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nivolumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pembrolizumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ipilimumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cholinergic system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acetylcholine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">muscarinic receptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nicotinic receptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ShcD adaptor protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amoeboid motility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rac1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DOCK4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma PDX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">target therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer stem cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">slow cycling phenotype</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">OXPHOS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer associated fibroblast</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanomagenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">checkpoint inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytokines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">machine learning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Support Vector Machine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">principal component analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BCL2L10</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STAT3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ABT-737</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Bcl-2 family</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ML258</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HuR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MITF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">siRNA</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3304-4</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3303-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Del Bufalo, Donatella</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carè, Alessandra</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Facchiano, Antonio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Del Bufalo, Donatella</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carè, Alessandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:39:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338112710004498&amp;Force_direct=true</subfield><subfield code="Z">5338112710004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338112710004498</subfield></datafield></record></collection>

Similar Items